21, 25-27 Notably, crosstalk between the canonical SMAD signaling pathway and the MAPK pathway is well described (reviewed28). However, the physiologic relevance of the ERK/MAPK signaling Osimertinib pathway in iron homeostasis in vivo is still unknown. Recent studies suggest a role for inhibitory SMAD7 in hepcidin regulation and iron homeostasis.10, 17, 23, 24 Inhibitory SMADs function as feedback inhibitors
of the BMP/TGF-β pathway by interacting with type I receptors to block their phosphorylation or to promote receptor dephosphorylation or degradation.8 Hepatic Smad7 mRNA is induced by chronic dietary iron loading in mice concordantly with hepcidin and Pifithrin-�� purchase Id1 mRNA,17 and SMAD7 was recently
shown to be a specific inhibitor of hepcidin transcription in vitro.10 Alterations in hepatic SMAD7 mRNA expression have also been found in hemochromatosis patients.23, 24 However, the physiologic significance and timing of SMAD7 activation upon iron administration in vivo need further evaluation. Here we investigated the molecular mechanisms by which iron is sensed to regulate BMP6-SMAD signaling and hepcidin expression. We performed a detailed time course of both acute and chronic enteral iron administration in mice to obtain different conditions of body iron perturbation including isolated increases of either transferrin saturation (Tf sat) or LIC. Then we dissected the BMP6-SMAD signaling pathway from the induction of tissue-specific Bmp6 ligand mRNA expression, to the activation of intracellular signal mediators including P-Smad1/5/8 and Erk1/2 proteins, to the modulation of target transcript expression including hepcidin
(Hamp, also known as Hamp1), Id1, and Smad7. click here Our aim was to determine how tissue and circulating iron stimulate the Bmp6-Smad signaling pathway to regulate hepcidin expression, and whether the Erk1/2 pathway is stimulated by iron. BMP, bone morphogenetic protein; CBC, complete blood count; ERK1/2, extracellular signal-regulated kinases 1 and 2; HAMP, hepcidin; HFE, hemochromatosis protein; HFE2, hemojuvelin; LIC, liver iron content; MAPK, mitogen activated protein kinase; P-ERK1/2, phosphorylated ERK1/2 protein; P-SMAD1/5/8, phosphorylated SMAD1, SMAD5, and SMAD8 protein; Tf sat, transferrin saturation; TFR2, transferrin receptor 2. All animal protocols were approved by the Institutional Animal Care and Use Committee at the Massachusetts General Hospital and used C57Bl/6 male mice. For chronic iron administration experiments, 7-week-old mice were sacrificed at time zero (Baseline) or received a high iron diet (2% carbonyl iron, TD.08496, Harlan Teklad) for 24 hours to 3 weeks prior to sacrifice (n = 6 per group).
No related posts.